Naropin

Should only be administered by trained clinicians. Have resuscitative equipment immediately available. Unintended IV inj may result in cardiac arrhythmia or arrest (esp. in elderly and those with concomitant heart disease); prolonged resuscitative efforts may be required. Not for emergency situations. Risk of chondrolysis (with intra-articular infusions after arthroscopic or other procedures). Risk of methemoglobinemia (esp. in G6PD deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants <6 months of age, concurrent exposure to oxidizing agents or metabolites); monitor closely. Have protocol for malignant hyperthermia management available. Impaired cardiovascular function. Hypotension. Hypovolemia. Heart block. In brachial plexus block: caution when using ropivacaine 300mg dose. Use in ophthalmic surgery (retrobulbar blocks): not recommended. Hepatic disease. Renal impairment. Debilitated, elderly, acutely ill: reduce dose. Labor & delivery; monitor fetal heart rate. Pregnancy. Nursing mothers.